Triangulating brain alterations in anorexia nervosa: a multimodal investigation of magnetic resonance spectroscopy, morphometry and blood-based biomarkers.
Journal
Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664
Informations de publication
Date de publication:
12 08 2023
12 08 2023
Historique:
received:
28
10
2022
accepted:
03
08
2023
revised:
02
08
2023
medline:
16
8
2023
pubmed:
13
8
2023
entrez:
12
8
2023
Statut:
epublish
Résumé
The acute state of anorexia nervosa (AN) is associated with widespread reductions in cortical gray matter (GM) thickness and white matter (WM) volume, suspected changes in myelin content and elevated levels of the neuronal damage marker neurofilament light (NF-L), but the underlying mechanisms remain largely unclear. To gain a deeper understanding of brain changes in AN, we applied a multimodal approach combining advanced neuroimaging methods with analysis of blood-derived biomarkers. In addition to standard measures of cortical GM thickness and WM volume, we analyzed tissue-specific profiles of brain metabolites using multivoxel proton magnetic resonance spectroscopy, T1 relaxation time as a proxy of myelin content leveraging advanced quantitative MRI methods and serum NF-L concentrations in a sample of 30 female, predominately adolescent patients with AN and 30 age-matched female healthy control participants. In patients with AN, we found a reduction in GM cortical thickness and GM total N-acetyl aspartate. The latter predicted higher NF-L levels, which were elevated in AN. Furthermore, GM total choline was elevated. In WM, there were no group differences in either imaging markers, choline levels or N-acetyl aspartate levels. The current study provides evidence for neuronal damage processes as well as for increased membrane lipid catabolism and turnover in GM in acute AN but no evidence for WM pathology. Our results illustrate the potential of multimodal research including tissue-specific proton magnetic resonance spectroscopy analyses to shed light on brain changes in psychiatric and neurological conditions, which may ultimately lead to better treatments.
Identifiants
pubmed: 37573444
doi: 10.1038/s41398-023-02580-6
pii: 10.1038/s41398-023-02580-6
pmc: PMC10423271
doi:
Substances chimiques
Biomarkers
0
Choline
N91BDP6H0X
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
277Informations de copyright
© 2023. Springer Nature Limited.
Références
J Clin Med. 2021 Dec 30;11(1):
pubmed: 35011927
Am J Clin Nutr. 2012 Mar;95(3):548-54
pubmed: 22301927
Transl Psychiatry. 2019 Aug 1;9(1):180
pubmed: 31371701
Prog Neurobiol. 2007 Feb;81(2):89-131
pubmed: 17275978
Neuroimage. 1999 Feb;9(2):179-94
pubmed: 9931268
Transl Psychiatry. 2019 Jun 4;9(1):159
pubmed: 31164627
Magn Reson Med. 2014 Jul;72(1):20-5
pubmed: 23900976
Neuroradiology. 2012 Jul;54(7):753-64
pubmed: 22210349
Biol Psychiatry. 2022 Nov 1;92(9):730-738
pubmed: 36031441
Nutrients. 2021 Feb 03;13(2):
pubmed: 33546416
Neuroimage. 2004;23 Suppl 1:S69-84
pubmed: 15501102
J Neuroimaging. 2021 Nov;31(6):1099-1110
pubmed: 34463008
PLoS One. 2019 Feb 28;14(2):e0210803
pubmed: 30818328
Nat Rev Drug Discov. 2008 May;7(5):426-37
pubmed: 18425072
Cells. 2020 Mar 27;9(4):
pubmed: 32230947
J Psychiatr Res. 2007 Dec;41(11):952-8
pubmed: 17112540
Dtsch Med Wochenschr. 2010 Apr;135(17):848-52
pubmed: 20408102
Neuroimage. 2010 Oct 15;53(1):1-15
pubmed: 20547229
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57
pubmed: 9881538
NMR Biomed. 2012 Dec;25(12):1392-400
pubmed: 22714729
Dev Neurosci. 1993;15(3-5):289-98
pubmed: 7805581
Psychopharmacology (Berl). 2017 Feb;234(3):421-426
pubmed: 27909746
Neuroimage. 2010 Jan 15;49(2):1271-81
pubmed: 19819338
Psychother Psychosom Med Psychol. 1997 Sep-Oct;47(9-10):365-76
pubmed: 9411465
MAGMA. 2015 Jun;28(3):259-70
pubmed: 25408107
Appetite. 2019 Aug 1;139:35-41
pubmed: 30981752
Neuroimage. 2014 Jun;93 Pt 2:176-88
pubmed: 23756203
Prog Neuropsychopharmacol Biol Psychiatry. 2010 Aug 16;34(6):1049-53
pubmed: 20580920
Neuroimage. 2016 Apr 15;130:214-222
pubmed: 26876474
Front Neurol. 2021 Mar 08;12:640239
pubmed: 33763021
Biol Psychiatry. 2018 Feb 1;83(3):224-234
pubmed: 28967386
Hum Brain Mapp. 2002 Nov;17(3):143-55
pubmed: 12391568
Mol Psychiatry. 1997 Jul;2(4):330-4
pubmed: 9246674
Neuroimage. 2014 Apr 15;90:60-73
pubmed: 24345388
NMR Biomed. 2021 May;34(5):e4484
pubmed: 33559967
Transl Psychiatry. 2021 Feb 9;11(1):86
pubmed: 33558486
J Am Acad Child Adolesc Psychiatry. 2022 Sep;61(9):1168-1181
pubmed: 35390458
Neuroimage. 2014 Jun;93 Pt 1:95-106
pubmed: 24607447
Neuroimage. 2009 Oct 15;48(1):63-72
pubmed: 19573611
Sci Rep. 2022 Feb 16;12(1):2589
pubmed: 35173174
J Clin Med. 2020 Apr 30;9(5):
pubmed: 32365843
Magn Reson Med. 2019 Aug;82(2):527-550
pubmed: 30919510
Neuroreport. 2004 Mar 1;15(3):549-53
pubmed: 15094521
Acta Neuropathol. 2010 Jan;119(1):37-53
pubmed: 19847447
J Am Acad Child Adolesc Psychiatry. 2021 Dec;60(12):1479-1490
pubmed: 33662496
Psychiatry Res. 2011 Mar 31;191(3):196-200
pubmed: 21310595
Transl Psychiatry. 2022 Mar 15;12(1):103
pubmed: 35292626
Int J Eat Disord. 1999 Sep;26(2):119-36
pubmed: 10422601